Results 151 to 160 of about 18,911,738 (262)

Enhanced in-vivo persistence and PET imaging performance of [⁶⁸Ga]Ga-DOTA-TMVP1446/GS5 as a VEGFR-3 radiotracer. [PDF]

EJNMMI Res
Wang J, Chen X, Cheng S, Li J, Sun Y, Song Y, Cai F, Li F, Jiang D, Xi L.   +9 more
europepmc   +1 more source

T2*-Weighted Imaging Performance in the Detection of Deep Endometriosis among Readers with Different Experience: Comparison with Conventional MRI Sequences. [PDF]

Diagnostics (Basel), 2022
Franco PN, Annibali S, Viganò S, Cazzella C, Marra C, Smedile A, Bonaffini PA, Marra P, Otero García MM, Reinhold C, Sironi S.   +10 more
europepmc   +1 more source

Preoperative circulating tumor cells integrated with imaging analysis for prognostic evaluation in head and neck squamous cell carcinoma

Molecular Oncology, EarlyView.
Detecting circulating tumor cells (CTCs) in blood before surgery may help predict outcomes in patients with head and neck squamous cell carcinoma (HNSCC). Here, we show when combined with tumor size and lymph node involvement from routine imaging, CTC status identifies high‐risk patients with poorer survival—offering a simple, minimally invasive tool ...
Susanne Flach, Gizem Abaci, Tom Huberty, Axel Lechner, Lukas Käsmann, Jens Ricke, Sophia Stöcklein, Martin Canis, Philipp Baumeister, Marianna Alunni‐Fabbroni   +9 more
wiley   +1 more source

Characterization of Breast Microcalcifications Using Dual-Energy CBCT: Impact of Detector Configuration on Imaging Performance-A Simulation Study. [PDF]

Sensors (Basel)
Karali E, Michail C, Fountos G, Kalyvas N, Valais I.   +4 more
europepmc   +1 more source

Epigenetic silencing of the liver‐specific lncRNA LUNAR promotes liver cancer progression via NOTCH activation

Molecular Oncology, EarlyView.
LUNAR is a liver‐specific long noncoding RNA (lncRNA) that is highly expressed in normal liver but becomes epigenetically silenced in hepatocellular carcinoma through promoter hypermethylation. Loss of LUNAR is associated with NOTCH activation, epithelial–mesenchymal transition, and metastasis, whereas restoring LUNAR restrains metastatic progression ...
Se Ha Jang, Hyung Seok Kim, Geum Ok Baek, Moon Gyeong Yoon, Su In Lee, Jee‐Yeong Jeong, Ji Eun Han, Soon Sun Kim, Jae Youn Cheong, Jung Woo Eun   +9 more
wiley   +1 more source

Pneumatically Assisted Microfluidic Probe for Enhanced Mass Spectrometry Imaging Performance. [PDF]

J Am Soc Mass Spectrom
Jiang LX, Laskin J.
europepmc   +1 more source

CEACAM1 participation in breast cancer progression

Molecular Oncology, EarlyView.
In invasive breast cancer (BC), CEACAM1 shifts from an apical to a uniform membranous/cytoplasmic pattern, or is lost, as tumors dedifferentiate, inversely tracking the Ki‐67 proliferative index. In MCF‐7 cells, only CEACAM1‐4L suppresses proliferation, repressing cell cycle and growth factor genes.
Mykola Lyndin, Irina Kube‐Golovin, Anatolii Romaniuk, Gunther Wennemuth   +3 more
wiley   +1 more source

Enhancing Biomarker Detection and Imaging Performance of Smartphone Fluorescence Microscopy Devices. [PDF]

Biosensors (Basel)
Sami MA, Tahir MN, Hassan U.
europepmc   +1 more source

Pharmacological chromatin remodeling enhances response to estrogen therapy in ER+ breast cancer

Molecular Oncology, EarlyView.
Estrogen therapy elicits clinical benefit in ~ 30% of patients with endocrine‐resistant estrogen receptor (ER)‐positive breast cancer. Based on findings that ER transcriptional activation underlies response to estrogen therapy, we tested the effects of epigenetic dysregulation via pharmacological inhibition of histone deacetylases (HDACi).
Anneka L. Johnson Thomas, Barbara Karakyriakou, Patricia C. Muskus, Alyssa M. Roberts, Justin Rendleman, Alexa Warren, Hanxu Lu, Kimberly A. Birmingham, Malone K. Friedman, Abigail E. Goen, Huijuan Yang, Owen M. Wilkins, Fred W. Kolling, Eugene Demidenko, Julie M. Jorns, Brock C. Christensen, Todd W. Miller   +16 more
wiley   +1 more source

Effects of excitation field amplitude on magnetic particle imaging performance: a modeling study. [PDF]

J Phys D Appl Phys
Azizi E, Li C, Gómez-Pastora J, He R, Wu K.   +4 more
europepmc   +1 more source